| Literature DB >> 26282603 |
Yen-Hung Lin1, Vin-Cent Wu1, Men-Tzung Lo2, Xue-Ming Wu3, Chi-Sheng Hung1, Kwan-Dun Wu1, Chen Lin2, Yi-Lwun Ho1, Michael Stowasser4, Chung-Kang Peng5.
Abstract
Excess aldosterone secretion in patients with primary aldosteronism (PA) impairs their cardiovascular system. Heart rhythm complexity analysis, derived from heart rate variability (HRV), is a powerful tool to quantify the complex regulatory dynamics of human physiology. We prospectively analyzed 20 patients with aldosterone producing adenoma (APA) that underwent adrenalectomy and 25 patients with essential hypertension (EH). The heart rate data were analyzed by conventional HRV and heart rhythm complexity analysis including detrended fluctuation analysis (DFA) and multiscale entropy (MSE). We found APA patients had significantly decreased DFAα2 on DFA analysis and decreased area 1-5, area 6-15, and area 6-20 on MSE analysis (all p < 0.05). Area 1-5, area 6-15, area 6-20 in the MSE study correlated significantly with log-transformed renin activity and log-transformed aldosterone-renin ratio (all p < = 0.01). The conventional HRV parameters were comparable between PA and EH patients. After adrenalectomy, all the altered DFA and MSE parameters improved significantly (all p < 0.05). The conventional HRV parameters did not change. Our result suggested that heart rhythm complexity is impaired in APA patients and this is at least partially reversed by adrenalectomy.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26282603 PMCID: PMC4539539 DOI: 10.1038/srep11249
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Clinical data of patients at baseline.
| Patient characteristics | APA (n = 20) | EH (n = 25) | P |
|---|---|---|---|
| Age, years | 45 ± 9 | 46 ± 11 | 0.666 |
| Male sex | 9 (45) | 11 (44) | 0.947 |
| History of hypertension, years | 5.4 ± 6.6 | 5.4 ± 4.9 | 0.982 |
| Body weight, kg | 67 ± 13 | 68 ± 12 | 0.791 |
| Body height, cm | 161 ± 8 | 164 ± 9 | 0.270 |
| Creatinine, mg/dL | 1.0 ± 0.3 | 0.9 ± 0.2 | 0.807 |
| SBP, mmHg | 148 ± 13 | 140 ± 17 | 0.079 |
| DBP, mmHg | 92 ± 11 | 87 ± 13 | 0.194 |
| Potassium, mmol/L | 3.3 ± 0.8 | 4.3 ± 0.5 | <0.001 |
| PAC, ng/dL | 50 ± 36 | 31 ± 23 | 0.029 |
| PRA, ng/mL/hr | 0.4 ± 0.5 | 8.9 ± 11.1 | 0.001 |
| ARR | 1932.8 ± 2797.1 | 23.6 ± 55.8 | 0.007 |
| Log PAC | 1.6 ± 0.3 | 1.4 ± 0.2 | 0.006 |
| Log PRA | −0.9 ± 0.9 | 0.6 ± 0.7 | <0.001 |
| Log ARR | 2.6 ± 0.9 | 0.9 ± 0.6 | <0.001 |
| LVMI, g/m2 | 135 ± 38 | 110 ± 27 | 0.028 |
| LVEF, % | 71 ± 7 | 73 ± 6 | 0.488 |
| Adenoma diameter on abdominal CT, mm | 15.5 ± 6.1 | — | — |
| Adenoma location (left/right side) | 16/4 | — | — |
| Number of hypertensive medication | 1.7 ± 0.9 | 1.8 ± 0.8 | 0.678 |
| Hypertensive Medication | |||
| CCB | 13 (65) | 15 (60) | 0.731 |
| ACEI | 0 (0) | 2 (8) | 0.495 |
| ARB | 5 (25) | 16 (64) | 0.036 |
| Thiazide | 3 (15) | 1 (4) | 0.309 |
| α-blocker | 9 (45) | 4(16) | 0.049 |
| β-blocker | 6 (30) | 8(32) | 0.885 |
| Spironolactone | 10 (50) | 1 (4) | 0.001 |
Values are mean ± SD or number (percentage). APA = aldosterone producing adenoma; EH = essential hypertension; SBP = systolic blood pressure; DBP = diastolic blood pressure; PAC = plasma aldosterone concentration; PRA = plasma renin activity; ARR = aldosterone-renin ratio; CCB = calcium channel blocker; ACE-I = angiotensin converting enzyme inhibitor; ARB = angiotensin receptor blocker; LVMI = left ventricular mass index; LVEF: left ventricular ejection fraction; CT = computed tomography.
Holter parameter of patients at baseline.
| APA (n = 20) | EH (n = 25) | P | |
|---|---|---|---|
| Mean, mm | 750 ± 102 | 739 ± 121 | 0.746 |
| SDNN, mm | 72 ± 18 | 74 ± 23 | 0.718 |
| pNN20, mm | 20 ± 16 | 21 ± 13 | 0.733 |
| pNN50, mm | 2.8 ± 4.0 | 3.2 ± 3.8 | 0.683 |
| High frequency | 107 ± 115 | 116 ± 113 | 0.814 |
| Low frequency | 263 ± 154 | 314 ± 167 | 0.297 |
| LF/HF ratio | 4.0 ± 2.3 | 4.2 ± 2.9 | 0.799 |
| Very low frequency | 968 ± 376 | 1018 ± 488 | 0.711 |
| α1 | 1.29 ± 0.19 | 1.26 ± 0.20 | 0.613 |
| α2 | 1.19 ± 0.09 | 1.13 ± 0.10 | 0.046 |
| Area 1–5 | 5.4 ± 1.3 | 6.4 ± 1.0 | 0.006 |
| Slope 5 | 0.067 ± 0.055 | 0.052 ± 0.058 | 0.393 |
| Area 6–15 | 13.4 ± 2.4 | 14.9 ± 1.8 | 0.023 |
| Area 6–20 | 20.4 ± 3.6 | 22.4 ± 2.7 | 0.036 |
Values are mean ± SD. APA = aldosterone producing adenoma; EH = essential hypertension; SDNN = standard deviation of normal RR intervals; pNN20 = percentage of the absolute change in consecutive normal RR interval exceeds 20 ms; pNN50 = percentage of the absolute change in consecutive normal RR interval exceeds 50 ms; LF/HF = the ratio between low and high frequency components.
Figure 1The entropy over different time scales.
a) The square open symbols represented the entropy of patients with EH, and the black solid dots the entropy of APA patients before surgery. b) The black solid dots represented the entropy of APA patients before surgery, and the open circles the entropy of APA patients after surgery. *p < 0.05.
Correlation between clinical parameters and non-linear Holter parameters (n = 45).
| DFAα2 | ||||
|---|---|---|---|---|
| Age, years | 0.038 | −0.048 | −0.053 | −0.065 |
| Male sex | −0.148 | 0.044 | 0.110 | 0.110 |
| History of hypertension, years | −0.086 | 0.079 | 0.091 | 0.067 |
| Number of hypertensive medication | 0.272 | −0.052 | −0.047 | −0.041 |
| Body height, cm | 0.162 | 0.014 | −0.090 | −0.083 |
| Body weight, kg | −0.128 | 0.002 | 0.217 | 0.208 |
| Log PAC | 0.098 | −0.190 | −0.117 | −0.104 |
| Log PRA | −0.177 | 0.402 | 0.395 | 0.379 |
| Log ARR | 0.186 | −0.416 | −0.393 | −0.376 |
| Potassium, mmol/L | −0.101 | 0.181 | 0.356 | 0.355 |
| SBP, mmHg | −0.103 | −0.308 | −0.014 | −0.012 |
| DBP, mmHg | −0.089 | −0.015 | −0.015 | −0.024 |
| LVMI, g/m2 | 0.000 | −0.263 | −0.200 | −0.212 |
| LVEF, % | −0.111 | 0.087 | −0.037 | −0.049 |
Values are correlation coefficients. PAC = plasma aldosterone concentration; PRA = plasma renin activity; ARR = aldosterone-renin ratio; SBP = systolic blood pressure; DBP = diastolic blood pressure; *p < = 0.01; #p < 0.05.
Clinical parameters before and one year after adrenalectomy (n = 20).
| Before operation | After operation | ||
|---|---|---|---|
| SBP, mmHg | 148 ± 13 | 144 ± 16 | 0.416 |
| DBP, mmHg | 92 ± 11 | 90 ± 12 | 0.401 |
| Number of hypertensive medication | 1.8 ± 1.1 | 0.7 ± 0.8 | <0.001 |
| Potassium, mmol/L | 3.3 ± 0.8 | 4.3 ± 0.5 | <0.001 |
| Log PAC | 1.6 ± 0.3 | 1.5 ± 0.2 | 0.032 |
| Log PRA | −0.9 ± 0.9 | −0.1 ± 0.7 | 0.003 |
| Log ARR | 2.6 ± 0.9 | 1.5 ± 0.7 | 0.002 |
| LVMI, g/m2 | 135 ± 38 | 113 ± 24 | 0.004 |
| LVEF, % | 71 ± 7 | 70 ± 9 | 0.569 |
Values are mean ± SD. SBP = systolic blood pressure; DBP = diastolic blood pressure; PAC = plasma aldosterone concentration; PRA = plasma renin activity; ARR = aldosterone-renin ratio; LVMI = left ventricular mass index; LVEF: left ventricular ejection fraction.
Holter parameters before and one year after adrenalectomy (n = 20).
| Before operation | After operation | P | |
|---|---|---|---|
| Mean, mm | 750 ± 102 | 706 ± 119 | 0.075 |
| SDNN, mm | 72 ± 18 | 70 ± 19 | 0.798 |
| pNN20, mm | 20 ± 16 | 16 ± 14 | 0.208 |
| pNN50, mm | 2.8 ± 4.0 | 2.8 ± 4.0 | 0.473 |
| High frequency | 107 ± 115 | 98 ± 120 | 0.740 |
| Low frequency | 263 ± 154 | 352 ± 357 | 0.243 |
| LF/HF ratio | 4.0 ± 2.3 | 5.1 ± 3.5 | 0.188 |
| Very low frequency | 968 ± 376 | 829 ± 373 | 0.122 |
| α1 | 1.29 ± 0.19 | 1.37 ± 0.17 | 0.169 |
| α2 | 1.19 ± 0.09 | 1.13 ± 0.13 | 0.043 |
| Area 1–5 | 5.4 ± 1.3 | 6.3 ± 1.1 | 0.007 |
| Slope 5 | 0.067 ± 0.055 | 0.098 ± 0.051 | 0.035 |
| Area 6–15 | 13.4 ± 2.4 | 15.5 ± 1.8 | 0.001 |
| Area 6–20 | 20.4 ± 3.6 | 23.4 ± 2.7 | 0.003 |
Values are mean ± SD. Values are mean ± SD. APA = aldosterone producing adenoma; EH = essential hypertension; SDNN = standard deviation of normal RR intervals; pNN20 = percentage of absolute differences in normal RR intervals greater than 20 ms; pNN50 = percentage of absolute differences in normal RR intervals greater than 50 ms; LF/HF = low frequency to high frequency.
Figure 2Quantification of MSE: The summation of the entropy over different scales can quantify the complexity over certain time scales.
Four parameters of the MSE were assessed. The first two of these were the linear-fitted slope between scales 1–5 (slope 5); the area under curve between scale 1–5 (area 1–5) to represent complexity between short scales. For longer scales, the common profile of entropy gradually increases as the time scale elongates and reaches a plateau around scale 15 where information richness can be accumulated rapidly if the system can respond well. We therefore calculated both the area under curve between scales 6–15 (area 6–15) and 6–20 (area 6–20) to represent complexity between long scales.